Roth Capital removed Peregrine Pharmaceuticals (PPHM) from its Focus List
Tweet
Share
E-mailGet Alerts PPHM Hot Sheet
Price: $0.61 --0%
Rating Summary:
3 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 7 | New: 7
Rating Summary:
3 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 7 | New: 7
Join SI Premium – FREE
Roth Capital removed Peregrine Pharmaceuticals Inc. (Nasdaq: PPHM) from its Focus List.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wells Fargo Downgrades Fidelity National Information Services (FIS) to Equal Weight
- NVIDIA (NVDA) PT Raised to $352 at Raymond James
- RBC Capital Downgrades ARB Corp Ltd (ARB:AU) to Sector Perform
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
Roth CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
